title: Malignant acanthosis nigricans and endometrioid adenocarcinoma of the parametrium: the search for malignancy.
abstract: Malignant acanthosis nigricans is recognized as a cutaneous sign of internal malignancy, usually an adenocarcinoma. Although cases of malignant acanthosis nigricans have been associated with cervical, ovarian, and endometrial neoplasms, we describe a case with a rarely if ever reported association, endometrioid adenocarcinoma of the parametrium.
authors.affiliation: Cleveland Clinic Foundation, Ohio, USA.
authors.forename: Sharon J
authors.initials: SJ
authors.lastname: Longshore
authors.forename: James S
authors.initials: JS
authors.lastname: Taylor
authors.forename: Alexander
authors.initials: A
authors.lastname: Kennedy
authors.forename: Saul
authors.initials: S
authors.lastname: Nurko
mesh_terms: D000052:Acanthosis Nigricans / Q000150:complications* / Q000473:pathology; D000230:Adenocarcinoma / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001707:Biopsy, Needle; D016190:Carboplatin / Q000008:administration & dosage; D017024:Chemotherapy, Adjuvant; D016889:Endometrial Neoplasms / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007044:Hysterectomy / Q000379:methods; D007150:Immunohistochemistry; D017239:Paclitaxel / Q000008:administration & dosage; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D016190:Carboplatin; D017239:Paclitaxel